KCNN4 and breast cancer: To test whether oncogenic properties of SK4 directly stem from the tumour cells, all animal studies were supported by a parallel analysis of mammary tumour cells derived from PyMT (and cNeu) transgenic tumours in the presence and absence of SK4 channels.